TBPH

Theravance Biopharma Inc · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website eravance.com
Employees(FY) 111
ISIN KYG8807B1068

Performance

-2.84%

-3.33%

+16.81%

+13.09%

-14.68%

YTD

-12.58%

Profile

Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States and Europe. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). The company's product includes Ampreloxetine, an investigational norepinephrine reuptake inhibitor that has completed Phase III study for neurogenic orthostatic hypotension; and TRELEGY for the treatment of COPD and asthma. It has licensing and collaboration agreements with Pfizer Inc. for its preclinical skin-selective pan-JAK inhibitor program, as well as Viatris Inc. Theravance Biopharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands.

Advanced Technical Analysis

Technical Analysis of TBPH 2024-12-20

The stock indicators reflect a predominantly neutral sentiment, with the Moving Average Score at 50 indicating a balanced trend, while the Oscillators Score of 36 suggests bearish momentum, and the Technical Score of 43 reinforces the overall neutral outlook. This combination implies that while there is no strong bullish signal, caution is warra...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of TBPH

Stock Rank

Recent News & Updates

2024-12-19 08:00
Government Contractor KBR, Recently Hit by DOGE Fears, Draws Activist Investor(The Wall Street Journal)
2024-12-17 06:00
Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference(PR Newswire)
2024-12-16 17:00
Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference(Prnewswire)
2024-12-11 22:30
Theravance Bio (TBPH) Up 3.7% Since Last Earnings Report: Can It Continue?(Yahoo Finance)
2024-12-11 07:37
The past five years for Theravance Biopharma (NASDAQ:TBPH) investors has not been profitable(Simply Wall St.)
2024-11-20 06:00
Theravance Biopharma to Participate in an Upcoming Investor Conference(PR Newswire)
2024-11-19 17:00
Theravance Biopharma to Participate in an Upcoming Investor Conference(Prnewswire)
2024-11-14 07:20
Theravance Biopharma Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags(Simply Wall St.)
2024-11-13 11:28
Theravance's Q3 Loss Narrower Than Expected, Revenues Rise Y/Y(Zacks)
2024-11-12 16:05
Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value(PR Newswire)
2024-11-12 13:22
Theravance Biopharma Inc (TBPH) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...(Yahoo Finance)
2024-11-12 05:05
Theravance Biopharma (TBPH) Reports Q3 Loss, Tops Revenue Estimates(Yahoo Finance)
2024-11-12 03:05
Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value(Prnewswire)
2024-11-11 10:46
Will These 5 Biotech Stocks Surpass Q3 Earnings Forecasts?(Zacks)
2024-11-11 07:47
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance(Zacks)
2024-11-10 18:16
What To Expect From Theravance Biopharma Inc (TBPH) Q3 2024 Earnings(Yahoo Finance)
2024-11-08 07:18
5 Small Drug Stocks to Buy as Trump Gets Re-Elected(Zacks)
2024-10-23 18:00
Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024(Prnewswire)
2024-10-17 21:00
Theravance Announces Publication of YUPELRI (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease(Prnewswire)
2024-09-09 23:01
Seth Klarman's Complete Exit from Theravance Biopharma Inc(Yahoo Finance)
2024-09-03 23:30
Theravance Bio (TBPH) Up 2.2% Since Last Earnings Report: Can It Continue?(Yahoo Finance)
2024-08-26 18:00
Theravance Biopharma to Participate in an Upcoming Investor Conference(Prnewswire)
2024-08-14 05:03
Seth Klarman's Strategic Reduction in Theravance Biopharma Inc(Yahoo Finance)
2024-08-06 10:56
Theravance (TBPH) Q2 Loss Wider Than Expected, Revenues Rise Y/Y(Zacks)
2024-08-05 18:00
Theravance Biopharma (TBPH) Reports Q2 Loss, Lags Revenue Estimates(Zacks)
2024-08-05 04:05
Theravance Biopharma, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update(Prnewswire)
2024-07-25 06:00
Theravance Biopharma to Participate in an Upcoming Investor Conference(PR Newswire)
2024-07-24 18:00
Theravance Biopharma to Participate in an Upcoming Investor Conference(Prnewswire)
2024-07-24 07:38
Theravance Biopharma, Inc. (NASDAQ:TBPH): When Will It Breakeven?(Simply Wall St.)
2024-07-22 06:00
Theravance Biopharma to Report Second Quarter 2024 Financial Results on August 5, 2024(PR Newswire)

Page 1 of 7

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.